- 1.
Huyghe E, Matsuda T, Thonneau P. Increasing incidence of testicular cancer worldwide: a review. J Urol 2003; 170: 5 – 11.
- 2.
Paulozzi LJ. International trends in rates of hypospadias and cryptorchidism. Environ Health Perspect 1999; 107: 297 – 302.
- 3.
Carlsen E, Giwercman A, Keiding N et al. Evidence for decreasing quality of semen during past 50 years. BMJ 1992; 305: 609 – 13.
- 4.
Sharpe RM, Irvine DS. How strong is the evidence of a link between environmental chemicals and adverse effects on human reproductive health? BMJ 2004; 328: 447 – 51.
- 5.
Skakkebæk NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 2001; 16: 972 – 8.
- 6.
Boisen KA, Kaleva M, Main KM et al. Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet 2004; 363: 1264 – 9.
- 7.
Toppari J, Kaleva M, Virtanen HE. Trends in the incidence of cryptorchidism and hypospadias, and methodological limitations of registry-based data. Hum Reprod Update 2001; 7: 282 – 6.
- 8.
Aschim EL, Haugen TB, Tretli S et al. Risk factors for hypospadias in Norwegian boys – association with testicular dysgenesis syndrome? Int J Androl 2004; 27: 213 – 21.
- 9.
Jørgensen N, Carlsen E, Nermoen I et al. East-West gradient in semen quality in the Nordic-Baltic area: a study of men from the general population in Denmark, Norway, Estonia and Finland. Hum Reprod 2002; 17: 2199 – 208.
- 10.
Jacobsen R, Møller H, Thoresen SO et al. Trends in testicular cancer incidence in the Nordic countries, focusing on the recent decrease in Denmark. Int J Androl 2006; 29: 199 – 204.
- 11.
Boisen KA, Chellakooty M, Schmidt IM et al. Hypospadias in a cohort of 1072 Danish newborn boys: prevalence and relationship to placental weight, anthropometrical measurements at birth, and reproductive hormone levels at three months of age. J Clin Endocrinol Metab 2005; 90: 4041 – 6.
- 12.
Richthoff J, Rylander L, Hagmar L et al. Higher sperm counts in Southern Sweden compared with Denmark. Hum Reprod 2002; 17: 2468 – 73.
- 13.
Sharpe RM. The «oestrogen hypothesis» – where do we stand now? Int J Androl 2003; 26: 2 – 15.
- 14.
Sharpe RM, Skakkebæk NE. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 1993; 341: 1392 – 5.
- 15.
Quigley CA, De Bellis A, Marschke KB et al. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 1995; 16: 271 – 321.
- 16.
Hemminki K, Li X. Cancer risks in second-generation immigrants to Sweden. Int J Cancer 2002; 99: 229 – 37.
- 17.
Aschim EL, Grotmol T, Tretli S et al. Is there an association between maternal weight and the risk of testicular cancer? An epidemiologic study of Norwegian data with emphasis on World War II. Int J Cancer 2005; 116: 327 – 30.
- 18.
Timms BG, Howdeshell KL, Barton L et al. Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra. Proc Natl Acad Sci USA 2005; 102: 7014 – 9.
- 19.
Swan SH, Main KM, Liu F et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect 2005; 113: 1056 – 61.
- 20.
Hardell L, Bavel B, Lindström G et al. In utero exposure to persistent organic pollutants in relation to testicular cancer risk. Int J Androl 2006; 29: 228 – 34.
- 21.
Aschim EL, Giwercman A, Stahl O et al. The RsaI polymorphism in the estrogen receptor-beta gene is associated with male infertility. J Clin Endocrinol Metab 2005; 90: 5343 – 8.
- 22.
Aschim EL, Nordenskjöld A, Giwercman A et al. Linkage between cryptorchidism, hypospadias, and GGN repeat length in the androgen receptor gene. J Clin Endocrinol Metab 2004; 89: 5105 – 9.
- 23.
Anway MD, Cupp AS, Uzumcu M et al. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 2005; 308: 1466 – 9.
()